annual CFF:
$193.45M-$223.03M(-53.55%)Summary
- As of today (June 22, 2025), ONC annual cash flow from financing activities is $193.45 million, with the most recent change of -$223.03 million (-53.55%) on December 31, 2024.
- During the last 3 years, ONC annual CFF has fallen by -$3.44 billion (-94.68%).
- ONC annual CFF is now -96.28% below its all-time high of $5.20 billion, reached on December 1, 2020.
Performance
ONC Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$33.78M-$29.25M(-646.78%)Summary
- As of today (June 22, 2025), ONC quarterly cash flow from financing activities is -$33.78 million, with the most recent change of -$29.25 million (-646.78%) on March 1, 2025.
- Over the past year, ONC quarterly CFF has dropped by -$196.07 million (-120.81%).
- ONC quarterly CFF is now -101.00% below its all-time high of $3.38 billion, reached on December 1, 2021.
Performance
ONC quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$2.62M-$196.07M(-101.35%)Summary
- As of today (June 22, 2025), ONC TTM cash flow from financing activities is -$2.62 million, with the most recent change of -$196.07 million (-101.35%) on March 1, 2025.
- Over the past year, ONC TTM CFF has dropped by -$601.26 million (-100.44%).
- ONC TTM CFF is now -100.05% below its all-time high of $5.20 billion, reached on December 1, 2020.
Performance
ONC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ONC Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.5% | -120.8% | -100.4% |
| 3 y3 years | -94.7% | -199.8% | -100.1% |
| 5 y5 years | +125.8% | -101.2% | -100.1% |
ONC Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.7% | +1119.7% | -109.7% | +69.4% | -100.1% | +93.6% |
| 5 y | 5-year | -96.3% | +1119.7% | -101.0% | +69.4% | -100.0% | +93.6% |
| alltime | all time | -96.3% | +1119.7% | -101.0% | +69.4% | -100.0% | +93.6% |
ONC Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$33.78M(+646.8%) | -$2.62M(-101.4%) |
| Dec 2024 | $193.45M(-53.6%) | -$4.52M(-135.7%) | $193.45M(-64.5%) |
| Sep 2024 | - | $12.66M(-45.0%) | $545.02M(+19.6%) |
| Jun 2024 | - | $23.02M(-85.8%) | $455.58M(-23.9%) |
| Mar 2024 | - | $162.29M(-53.2%) | $598.64M(+43.7%) |
| Dec 2023 | $416.48M(-2295.3%) | $347.05M(-552.0%) | $416.48M(-1117.4%) |
| Sep 2023 | - | -$76.78M(-146.2%) | -$40.94M(-126.2%) |
| Jun 2023 | - | $166.08M(-935.9%) | $156.09M(-666.1%) |
| Mar 2023 | - | -$19.87M(-82.0%) | -$27.57M(+45.3%) |
| Dec 2022 | -$18.97M(-100.5%) | - | - |
| Dec 2022 | - | -$110.37M(-191.8%) | -$18.97M(-100.5%) |
| Sep 2022 | - | $120.24M(-784.0%) | $3.48B(+0.3%) |
| Jun 2022 | - | -$17.58M(+56.0%) | $3.47B(-1.5%) |
| Mar 2022 | - | -$11.27M(-100.3%) | $3.52B(-3.3%) |
| Dec 2021 | $3.64B(-30.1%) | $3.38B(+2999.3%) | $3.64B(+529.3%) |
| Sep 2021 | - | $109.21M(+206.5%) | $577.91M(-76.5%) |
| Jun 2021 | - | $35.63M(-66.8%) | $2.46B(-1.8%) |
| Mar 2021 | - | $107.42M(-67.0%) | $2.51B(-51.8%) |
| Dec 2020 | $5.20B(+5972.4%) | $325.66M(-83.7%) | $5.20B(+6.6%) |
| Sep 2020 | - | $1.99B(+2361.9%) | $4.88B(+67.6%) |
| Jun 2020 | - | $80.99M(-97.1%) | $2.91B(+2.3%) |
| Mar 2020 | - | $2.80B(>+9900.0%) | $2.84B(+3220.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $85.68M(-94.9%) | $2.20M(-91.3%) | $85.68M(-7.2%) |
| Sep 2019 | - | $25.14M(+63.4%) | $92.28M(-90.2%) |
| Jun 2019 | - | $15.38M(-64.2%) | $938.40M(-3.2%) |
| Mar 2019 | - | $42.96M(+388.1%) | $969.60M(-42.6%) |
| Dec 2018 | $1.69B(+244.8%) | $8.80M(-99.0%) | $1.69B(+0.3%) |
| Sep 2018 | - | $871.25M(+1770.3%) | $1.68B(+46.1%) |
| Jun 2018 | - | $46.58M(-93.9%) | $1.15B(-7.9%) |
| Mar 2018 | - | $763.90M(>+9900.0%) | $1.25B(+155.3%) |
| Dec 2017 | $490.36M(+28.7%) | $3.05M(-99.1%) | $490.36M(-28.5%) |
| Sep 2017 | - | $339.71M(+134.2%) | $686.00M(+93.8%) |
| Jun 2017 | - | $145.07M(+5627.1%) | $353.93M(+65.9%) |
| Mar 2017 | - | $2.53M(-98.7%) | $213.39M(-44.0%) |
| Dec 2016 | $380.90M(+269.1%) | $198.69M(+2500.7%) | $380.90M(+109.2%) |
| Sep 2016 | - | $7.64M(+69.0%) | $182.09M(+0.7%) |
| Jun 2016 | - | $4.52M(-97.3%) | $180.82M(-33.8%) |
| Mar 2016 | - | $170.05M(<-9900.0%) | $273.25M(+164.8%) |
| Dec 2015 | $103.20M(+97.8%) | -$119.00K(-101.9%) | $103.20M(-0.1%) |
| Sep 2015 | - | $6.37M(-93.4%) | $103.32M(+6.6%) |
| Jun 2015 | - | $96.95M(>+9900.0%) | $96.95M(>+9900.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $52.16M(<-9900.0%) | - | - |
| Dec 2013 | -$482.00K | - | - |
FAQ
- What is BeOne Medicines annual cash flow from financing activities?
- What is the all time high annual CFF for BeOne Medicines?
- What is BeOne Medicines annual CFF year-on-year change?
- What is BeOne Medicines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for BeOne Medicines?
- What is BeOne Medicines quarterly CFF year-on-year change?
- What is BeOne Medicines TTM cash flow from financing activities?
- What is the all time high TTM CFF for BeOne Medicines?
- What is BeOne Medicines TTM CFF year-on-year change?
What is BeOne Medicines annual cash flow from financing activities?
The current annual CFF of ONC is $193.45M
What is the all time high annual CFF for BeOne Medicines?
BeOne Medicines all-time high annual cash flow from financing activities is $5.20B
What is BeOne Medicines annual CFF year-on-year change?
Over the past year, ONC annual cash flow from financing activities has changed by -$223.03M (-53.55%)
What is BeOne Medicines quarterly cash flow from financing activities?
The current quarterly CFF of ONC is -$33.78M
What is the all time high quarterly CFF for BeOne Medicines?
BeOne Medicines all-time high quarterly cash flow from financing activities is $3.38B
What is BeOne Medicines quarterly CFF year-on-year change?
Over the past year, ONC quarterly cash flow from financing activities has changed by -$196.07M (-120.81%)
What is BeOne Medicines TTM cash flow from financing activities?
The current TTM CFF of ONC is -$2.62M
What is the all time high TTM CFF for BeOne Medicines?
BeOne Medicines all-time high TTM cash flow from financing activities is $5.20B
What is BeOne Medicines TTM CFF year-on-year change?
Over the past year, ONC TTM cash flow from financing activities has changed by -$601.26M (-100.44%)